FINWIRES · TerminalLIVE
FINWIRES

伊朗战争和平协议前景黯淡,油价小幅上涨

-- 周四早盘,油价小幅上涨,美国和伊朗在结束这场战争方面进展甚微。这场战争造成了史上最大规模的供应冲击,波斯湾地区的石油运输被封锁在霍尔木兹海峡。 6月交割的西德克萨斯中质原油(WTI)价格上涨0.33美元,至每桶93.29美元;6月交割的布伦特原油价格上涨0.50美元,至每桶102.41美元。 美国和伊朗的谈判仍处于僵局。伊朗拒绝谈判,只要美国海军继续封锁其港口,伊朗就不会进行谈判;而美国则拒绝解除封锁。伊朗正在霍尔木兹海峡袭击船只。霍尔木兹海峡是全球20%石油需求(由波斯湾国家供应)的咽喉要道。与此同时,有报道称,美军正在印度洋登船检查伊朗船只。 “伊朗领导层将解除美国封锁作为恢复谈判的先决条件,一位高级官员甚至称此举为军事侵略行为。特朗普总统则表示,停火协议目前将继续维持,使冲突陷入一种没有空袭、船只活动极少、难以维系的平衡状态,”全球大宗商品策略和中东及北非研究主管赫利玛·克罗夫特写道。 自2月28日战争爆发以来,WTI原油价格已上涨37%,但由于市场对冲突即将结束的预期,油价已回落至4月7日触及的四年高点112.95美元以下。然而,如果交易员预期双方目前的僵局会持续下去,油价可能会再次测试这一四年高点。 “特朗普在四月份的大部分时间里都在吹嘘与伊朗达成协议指日可待。但现在看来,达成协议的可能性越来越小。过去一周,美国多边交易市场对霍尔木兹海峡何时重新开放的押注大幅下降。押注5月13日之前重新开放的押注自上周五以来下降了27%,目前仅为39%。市场对霍尔木兹海峡重新开放时间的预期正在迅速推迟。这意味着油价将会上涨,”SEB Research首席大宗商品分析师比雅恩·希尔德罗普(Bjarne Schieldrop)写道。

Related Articles

Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.

$HIG
Research

Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.

$BKR
Research

Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.

$WAB